The following are excerpts from the newsletter

• Safety issues with adding lidocaine to IV potassium infusions
• Potential packaging issues with BIOTRACE (sterile barium sulfate) and talc.
• Mix-ups between REMICADE (infliximab) and RITUXAN (rituximab).
• Your reports about LDPE containers make a difference with FDA (see FDA study)
• Effects of bad publicity after serious medical error.
• Subscriber feedback on the use of glucose oxidase test strips and "qhs" versus "nightly".
• Additions to ISMP's list of high-alert medications.
• The ISMP Patient Safety Contest
  

• Broselow tape: Measuring the changes from 1998 to today
• WorthRepeating...Roxanol involved in another serious error
• The publication of the FDA bar code label requirement
• Confusing expiration dates
• Accidental administration of HEMOCCULT SENSA developer solution into the patient's eyes
• ISMP teleconference, A Real-Life View of the Medication/Patient Safety Specialist, will be held on April 14, 2004. Click here to order the audio tapes for this teleconference.
• A Train-the-Trainer program will be presented on May 2-3, 2004, during a pre-conference workshop at the National Patient Safety Foundation Patient Safety Congress in Boston (ISMP is a convening organization)